Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Riyona Desvy Pratiwi"'
Autor:
Damai Ria Setyawati, Fransiska Christydira Sekaringtyas, Riyona Desvy Pratiwi, A’liyatur Rosyidah, Rohimmahtunnissa Azhar, Nunik Gustini, Gita Syahputra, Idah Rosidah, Etik Mardliyati, Tarwadi, Sjaikhurrizal El Muttaqien
Publikováno v:
Beilstein Journal of Nanotechnology, Vol 15, Iss 1, Pp 1105-1116 (2024)
Over recent decades, nanomedicine has played an important role in the enhancement of therapeutic outcomes compared to those of conventional therapy. At the same time, nanoparticle drug delivery systems offer a significant reduction in side effects of
Externí odkaz:
https://doaj.org/article/52a316e3fa9440ae84839e3024778d88
Autor:
Riyona Desvy Pratiwi, Sjaikhurrizal El Muttaqien, Nunik Gustini, Najla Salsabila Difa, Gita Syahputra, A’liyatur Rosyidah
Publikováno v:
ADMET and DMPK (2023)
Background and Purpose: Chitosan, a chitin deacetylation product, has been applied in nanoparticle or nano-chitosan for medical applications. However, the chitin extraction from crustacean shells and other natural resources, chitin deacetylation, and
Externí odkaz:
https://doaj.org/article/ddfdde78bc8744ff8681549fc152e9c2
Autor:
Iman Permana Maksum, Yosua Yosua, Ahmad Nabiel, Riyona Desvy Pratiwi, Sriwidodo Sriwidodo, Ukun M.S. Soedjanaatmadja
Publikováno v:
Heliyon, Vol 8, Iss 4, Pp e09306- (2022)
Human epidermal growth factor (hEGF) is a mitogenic protein widely used in pharmaceutical and cosmetic industries, thus recombinant DNA technology has been applied to meet the high demand for hEGF. The overexpression of recombinant protein in E. coli
Externí odkaz:
https://doaj.org/article/9adbc60e1c494187853cec4f8ba17a3e
Autor:
Riyona Desvy Pratiwi, Dian Fitria Agustiyanti, Tri Isyani Tungga Dewi, Nina Herlina, Kartika Sari Dewi, Yuliawati Yuliawati, Aminah Aminah, Asrul Muhamad Fuad
Publikováno v:
MCBS (Molecular and Cellular Biomedical Sciences), Vol 4, Iss 1, Pp 10-8 (2020)
Background: Recombinant human granulocyte colony stimulating factor (rhG-CSF) is a first line therapy for neutropenia. However, it is less affordable for most patients in developing and poor countries. Therefore, biosimilar products are developed to
Externí odkaz:
https://doaj.org/article/0910e20796964cf68d5a197e8d402b14
Publikováno v:
Indonesian Journal of Biotechnology, Vol 24, Iss 1, Pp 8-16 (2019)
Recombinant human epidermal growth factor (rh-EGF) has high value in therapies for h-EGF deficiency-related diseases. The expression of the h-EGF gene was designed by using the pET21b(+) vector and Escherichia coli BL21(DE3) as the expression host. I
Externí odkaz:
https://doaj.org/article/f7dc9888606c48559b5ba8e85c60f808
Publikováno v:
Indonesian Journal of Pharmacy, Vol 26, Iss 2, Pp 63-70 (2015)
A synthetic human gene of CSF3 (CSF3syn.Ec3), coding for hG-CSF was succesfully subcloned into pET32a(+) expression vector and fused with thioredoxin (Trx) at its N-terminal as fusion partner. The obtained fusion gene of Trx-CSF3syn within the recomb
Externí odkaz:
https://doaj.org/article/468b2fa7132e4201a0c0036e821731d1
Autor:
Asrul Muhamad Fuad, Ratna Annisa Utami, Dian Fitria Agustiyanti, Riyona Desvy Pratiwi, Hariyatun Hariyatun, Kartika Dewi
Publikováno v:
Microbiology and Biotechnology Letters. 49:148-156
Single-chain antibodies against epidermal growth factor receptor variant III (EGFRvIII) are potentially promising agents for developing antibody-based cancer treatment strategies. We described in our previous study the successful expression of an ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7527ccb8cf6cafca063c41450c6dc62
https://doi.org/10.48022/mbl.2006.06004
https://doi.org/10.48022/mbl.2006.06004
Publikováno v:
Biodiversitas Journal of Biological Diversity. 23
Adibah DI, Fuad AM, Budiarti S, Pratiwi RD. 2022. Construction of Saccharomyces cerevisiae KEX2-650 gene expression vector and its introduction into Escherichia coli DH5?. Biodiversitas 23: 4289-4296. Kex2 (EC 3.4.21.61) is a serine protease that bin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec6cda87e1b349614f872b23088d89fb
https://doi.org/10.13057/biodiv/d230853
https://doi.org/10.13057/biodiv/d230853
Autor:
Riyona Desvy Pratiwi, Viddy Agustian Rosyidi, Sabighoh Zanjabilla, Kartika Sari Dewi, Rio Novandra, Della Desvina, Heny Herawati
Publikováno v:
Pharmacy Reports. 2:46
Soy-based beverages offer numerous health benefits, but the presence of lipoxygenases causes an unpleasant off-flavor sensation that hinders acceptability. The addition of a suitable flavoring agent has been shown to enhance the acceptability of soy-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b35483bac65a400a3090db1927b1f64e
https://doi.org/10.51511/pr.46
https://doi.org/10.51511/pr.46
Autor:
Iman Permana, Maksum, Yosua, Yosua, Ahmad, Nabiel, Riyona Desvy, Pratiwi, Sriwidodo, Sriwidodo, Ukun M S, Soedjanaatmadja
Publikováno v:
Heliyon. 8(4)
Human epidermal growth factor (hEGF) is a mitogenic protein widely used in pharmaceutical and cosmetic industries, thus recombinant DNA technology has been applied to meet the high demand for hEGF. The overexpression of recombinant protein in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e1147c590a01b14870a8f0df9d24bc6c
https://pubmed.ncbi.nlm.nih.gov/35497033
https://pubmed.ncbi.nlm.nih.gov/35497033